REHOVOT, Israel — March 11, 2026: Kamada Ltd. (NASDAQ: KMDA), a specialty biopharmaceutical company, reported disappointing fourth-quarter 2025 financial results before market...
ANN ARBOR, Mich. — March 10, 2026: Esperion Therapeutics (NASDAQ: ESPR) reported fourth-quarter 2025 financial results before the opening bell today, revealing...